Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This is a large randomized, double-blind, placebo-controlled trial to determine the efficacy
of testosterone replacement on cancer-related fatigue in older men with incurable cancer who
report fatigue and have low testosterone levels.
Phase:
Phase 2
Details
Lead Sponsor:
Seattle Institute for Biomedical and Clinical Research